true 0001464343 0001464343 2023-01-01 2023-03-31 0001464343 atlc:CommonStockNoParValuePerShareCustomMember 2023-01-01 2023-03-31 0001464343 atlc:SeriesBPreferredStockNoParValuePerShareCustomMember 2023-01-01 2023-03-31 0001464343 atlc:SeniorNotesDue2026CustomMember 2023-01-01 2023-03-31 0001464343 2023-04-30 xbrli:shares
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q/A
(Amendment No. 1)
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2023
--12-31Q12023
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _______  to _______            
 
of
atlanticus.jpg
 
ATLANTICUS HOLDINGS CORPORATION
 
 
 
a Georgia Corporation
IRS Employer Identification No. 58-2336689
SEC File Number 0-53717
 
 
Five Concourse Parkway, Suite 300
Atlanta, Georgia 30328
(770) 828-2000
 
 
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (the "Act")
 
     
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which Registered
Common stock, no par value per share
ATLC
NASDAQ Global Select Market
Series B Preferred Stock, no par value per share
ATLCP
NASDAQ Global Select Market
Senior Notes due 2026
ATLCL
NASDAQ Global Select Market
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
   
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Indicate by check mark whether the Registrant is a shell company (as defined in Exchange Act Rule 12b- 2).      Yes    ☒  No
 
As of April 30, 2023, 14,464,185 shares of common stock, no par value, of Atlanticus were outstanding.
 
 

 
EXPLANATORY NOTE
 
This Amendment No. 1 on Form 10-Q/A (this “Amendment”) amends the original Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 filed by Atlanticus Holdings Corporation (the “Company”, “Atlanticus Holdings Corporation”, “Atlanticus”, “we”, “our”, “ours” and “us”) with the U.S. Securities and Exchange Commission (the “SEC”) on May 9, 2023 (the “Original Form 10-Q”). This Amendment does not change our consolidated financial statements as set forth in the Original Form 10-Q.
 
The purpose of this Amendment is to amend and restate Part I, Item 4 “Controls and Procedures” to reflect management’s conclusion that our disclosure controls and procedures were not effective at March 31, 2023 due to a material weakness in our internal control over financial reporting identified subsequent to the filing of our Original Form 10-Q. This material weakness did not result in any change to our consolidated financial statements as set forth in the Original Form 10-Q. As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by the Company’s principal executive officer and principal financial officer pursuant to Rule 13a-14(a) are being filed herewith as exhibits to this Amendment (Exhibits 31.1 and 31.2). Because no financial statements are contained within this Amendment, paragraph 3 of such certifications has been omitted. Additionally, a new certification of principal executive officer and principal financial officer pursuant to 18 U.S.C. Section 1350 is being filed herewith as an exhibit to this Amendment (Exhibit 32.1).
 
Other than the inclusion within this Amendment of new certifications required by management (and related amendment to the exhibit index to reflect the addition of such certifications), this Amendment speaks only as of the date of the Original Form 10-Q and does not modify or update any other disclosures contained in our Original Form 10-Q for other events or information subsequent to the date of the filing of the Original Form 10-Q. Specifically, there are no changes to our consolidated financial statements set forth in the Original Form 10-Q. This Amendment should be read in conjunction with the Original Form 10-Q and reports filed with the SEC subsequent to the Original Form 10-Q.
 
1

PART I
 
ITEM 4.
CONTROLS AND PROCEDURES
 
Evaluation of disclosure controls and procedures
 
On August 7, 2023, the Company’s management, including the principal executive officer and principal financial officer, in consultation with the Company’s independent registered public accounting firm, BDO USA, P.C. (“BDO”), determined that it was necessary for the Company to amend its prior disclosure in regards to Item 9A Controls and Procedures in the Form 10-K filed by the Company on March 15, 2023 (the “Form 10-K”). As part of the preparation of the Company’s June 30, 2023 interim financial statements, the Company’s management determined that they did not implement effective review controls and retain sufficient documentary evidence to support the precision of review over the development of cash flow forecasts used in the calculation of the fair value estimate of loans, interest and fees receivable at fair value. Thus, these controls were not operating effectively. This deficiency represents a material weakness in the Company’s internal control over financial reporting at March 31, 2023 and December 31, 2022.  A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. As a result, Management’s Report on Internal Control Over Financial Reporting included in Item 9A of the Company’s Form 10-K and BDO’s opinion relating to the effectiveness of the Company’s internal control over financial reporting as of December 31, 2022 included in the Form 10-K should no longer be relied upon. 
 
The material weakness described above did not result in a misstatement to the Company’s annual or interim consolidated financial statements.
 
Management, with the participation and supervision of our principal executive officer and our principal financial officer, have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Act) as of March 31, 2023, the end of the period covered by the Original Form 10-Q and this Amendment. The Company’s disclosure controls and procedures are designed to ensure that information the Company is required to disclose in reports that it files or submits under the Act is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.  Based on such evaluation, our principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures were not effective as of March 31, 2023 because of the material weakness described above.
 
Notwithstanding this material weakness, management has concluded that no material misstatements exist in the consolidated financial statements as filed in the Original Form 10-Q and such financial statements present fairly, in all material respects, our financial position as of March 31, 2023 and December 31, 2022, and the results of operations and cash flows for the three months ended March 31, 2023 and March 31, 2022, in conformity with accounting principles generally accepted in the United States. Accordingly, there are no changes to the Company’s previously-reported consolidated financial statements.
 
Remediation Plan
 
The Company’s management is committed to maintaining a strong internal control environment. In response to the material weakness identified above, management, with the oversight of the Audit Committee of the Board of Directors, evaluated the material weakness described above and designed a remediation plan to enhance the Company’s internal control environment. To remediate the material weakness, the Company’s management performed an evaluation of the relevant controls, and implemented procedures to enhance documentation, and retain incremental evidence that supports the effectiveness of controls related to the development and review of cash flow forecasts used in the calculation of the fair value estimate of loans, interest and fees receivable, at fair value. These enhanced procedures were implemented as of June 30, 2023, and will be monitored for effectiveness.
 
Changes in internal control over financial reporting
 
There were no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Act) during the quarter ended March 31, 2023, that materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.
 
Inherent limitation on the effectiveness of internal controls
 
The Company’s management, including its principal executive officer and principal financial officer, do not expect that the Company’s disclosure controls and procedures or the Company’s internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Due to inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
 
2

 
 
ITEM 6.
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
 
 
Exhibit
Number
 
Description of Exhibit
 
Incorporated by Reference from Atlanticus SEC Filings Unless Otherwise Indicated
31.1
 
Certification of Principal Executive Officer pursuant to Rule 13a-14(a)
 
Filed herewith
31.2
 
Certification of Principal Financial Officer pursuant to Rule 13a-14(a)
 
Filed herewith
32.1
 
Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350
 
Filed herewith
101.INS
 
Inline XBRL Instance Document
 
May 9, 2023, Form 10-Q, exhibit 101.INS
101.SCH
 
Inline XBRL Taxonomy Extension Schema Document
  May 9, 2023, Form 10-Q, exhibit 101.SCH
101.CAL
 
Inline XBRL Taxonomy Extension Calculation Linkbase Document
  May 9, 2023, Form 10-Q, exhibit 101.CAL
101.LAB
 
Inline XBRL Taxonomy Extension Label Linkbase Document
  May 9, 2023, Form 10-Q, exhibit 101.LAB
101.PRE
 
Inline XBRL Taxonomy Presentation Linkbase Document
  May 9, 2023, Form 10-Q, exhibit 101.PRE
101.DEF
 
Inline XBRL Taxonomy Extension Definition Linkbase Document
  May 9, 2023, Form 10-Q, exhibit 101.DEF
104
 
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
  Filed herewith
 
 
3

SIGNATURES
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
Atlanticus Holdings Corporation
 
     
       
November 8, 2023
By:
/s/ William R. McCamey
 
   
William R. McCamey
Chief Financial Officer
(duly authorized officer and principal financial officer)
 
 
 
4